Cost-effectiveness analysis of influenza vaccination with high-dose vaccine versus standard-dose quadrivalent vaccine in older adults in Spain
This analysis showed that vaccinating older adults in Spain with HD-QIV instead of SD-QIV would reduce cases of influenza, GP and ED visits, hospitalizations, deaths, and associated costs, and thus it should be the strategy of choice in a situation of budgetary constraints from either a societal or an NHS perspective.
Authors
- Paloma Pineda Palomo
- Juan Luis López-Belmonte (ORCID: https://orcid.org/0000-0001-8849-6415)
- Esther Redondo Margüello
- Ariadna Diaz-Aguiló
- Jose-María Abellán-Perpiñán
- Ángel Gil de Miguel
- Iván Sanz Muñoz
- Manel Farré
- Marco Pinel
Institutions
- Universidad Rey Juan Carlos (ES)
- Instituto de Salud Carlos III (ES)
- Sanofi (Spain) (ES)
- Instituto de Estudios de Ciencias de la Salud de Castilla y León (ES)
- Instituto Químico Biológico (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Centro de Investigación Biomédica en Red (ES)
- Madrid Health Service (ES)
- Universidad de Murcia (ES)
Publication Details
- Journal
- The European Journal of Health Economics
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1007/s10198-026-01894-8
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi